Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James T Boyd

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 24, 2018
Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement DisordersMaryka Quik, James T Boyd, Tanuja Bordia, et al.
Clinical Parkinsonism & Related Disorders|January 3, 2023
Pallidal stimulation-induced psychosis and suicidality in Parkinson's diseaseSebastian Hanna, Vala Palmadottir, Paul L Penar, et al.
Gait & Posture|March 24, 2015
Domains and correlates of clinical balance impairment associated with Huntington's diseaseJesse V Jacobs, James T Boyd, Penelope Hogarth, et al.
Clinical Neuropharmacology|January 13, 2016
Parkinsonism in Patients With Chronic Hepatitis C Treated With Interferons: Case Reports and Review of the LiteratureKirk J Wangensteen, Edward L Krawitt, Robert W Hamill, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|January 4, 2014
A novel presentation of an ocular geste antagoniste in cervical dystonia: a case reportJames T Boyd, Timothy J Fries, Keith J Nagle, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|January 1, 2021
Prevalence and Relationship of Rest Tremor and Action Tremor in Parkinson's DiseaseDeepak K Gupta, Massimo Marano, Cole Zweber, et al.
Sub-Cellular Biochemistry|December 11, 2012
Parkinson's diseaseTimothy R Mhyre, James T Boyd, Robert W Hamill, et al.
NPJ Parkinson'S Disease|February 2, 2018
Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristicsDavid G Standaert, James T Boyd, Per Odin, et al.
Neurology|July 20, 2016
Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort studyJames T Boyd, Kirk J Wangensteen, Edward L Krawitt, et al.
Clinical Parkinsonism & Related Disorders|July 28, 2021
A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studiesJames T Boyd, Cindy Zadikoff, Janet A Benesh, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 24, 2018
Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement DisordersMaryka Quik, James T Boyd, Tanuja Bordia, et al.
Clinical Parkinsonism & Related Disorders|January 3, 2023
Pallidal stimulation-induced psychosis and suicidality in Parkinson's diseaseSebastian Hanna, Vala Palmadottir, Paul L Penar, et al.
Gait & Posture|March 24, 2015
Domains and correlates of clinical balance impairment associated with Huntington's diseaseJesse V Jacobs, James T Boyd, Penelope Hogarth, et al.
Clinical Neuropharmacology|January 13, 2016
Parkinsonism in Patients With Chronic Hepatitis C Treated With Interferons: Case Reports and Review of the LiteratureKirk J Wangensteen, Edward L Krawitt, Robert W Hamill, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|January 4, 2014
A novel presentation of an ocular geste antagoniste in cervical dystonia: a case reportJames T Boyd, Timothy J Fries, Keith J Nagle, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|January 1, 2021
Prevalence and Relationship of Rest Tremor and Action Tremor in Parkinson's DiseaseDeepak K Gupta, Massimo Marano, Cole Zweber, et al.
Sub-Cellular Biochemistry|December 11, 2012
Parkinson's diseaseTimothy R Mhyre, James T Boyd, Robert W Hamill, et al.
NPJ Parkinson'S Disease|February 2, 2018
Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristicsDavid G Standaert, James T Boyd, Per Odin, et al.
Neurology|July 20, 2016
Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort studyJames T Boyd, Kirk J Wangensteen, Edward L Krawitt, et al.
Clinical Parkinsonism & Related Disorders|July 28, 2021
A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studiesJames T Boyd, Cindy Zadikoff, Janet A Benesh, et al.
Pageof 3